Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (56)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Nuojua-Huttunen, S.
Right arrow Articles by Martikainen, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nuojua-Huttunen, S.
Right arrow Articles by Martikainen, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 14, No. 3, 698-703, March 1999
© 1999 European Society of Human Reproduction and Embryology

Intrauterine insemination treatment in subfertility: an analysis of factors affecting outcome

Sinikka Nuojua-Huttunen1,4, Candido Tomas2, Risto Bloigu3, Leena Tuomivaara1 and Hannu Martikainen2

1 The Family Federation of Finland (The Oulu Infertility Clinic), Kiviharjuntie 11, FIN-90220 Oulu, 2 Department of Obstetrics and Gynecology, Oulu University Hospital, Kajaanintie 50, FIN-90220 Oulu, and 3 Medical Informatics, Faculty of Medicine, University of Oulu, Kajaanintie 52, FIN-90220 Oulu, Finland

A total of 811 intrauterine insemination (IUI) cycles in which clomiphene citrate/human menopausal gonadotrophin (HMG) was used for ovarian stimulation were analysed retrospectively to identify prognostic factors regarding treatment outcome. The overall pregnancy rate was 12.6% per cycle, the multiple pregnancy rate 13.7%, and the miscarriage rate 23.5%. Logistic regression analysis revealed five predictive variables as regards pregnancy: number of the treatment cycle (P = 0.009), duration of infertility (P = 0.017), age (P = 0.028), number of follicles (P = 0.031) and infertility aetiology (P = 0.045). The odds ratios for age <40 years, unexplained infertility aetiology (versus endometriosis) and duration of infertility <=6 years were 3.24, 2.79 and 2.33, respectively. A multifollicular ovarian response to clomiphene citrate/HMG resulted in better treatment success than a monofollicular response, and 97% of the pregnancies were obtained in the first four treatment cycles. The results indicate that clomiphene citrate/HMG/IUI is a useful and cost-effective treatment option in women <40 years of age with infertility duration <=6 years, who do not suffer from endometriosis.

Key words: clomiphene citrate/human menopausal gonadotrophin/infertility/intrauterine insemination/prognostic factors

4 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
S. Matsuzaki, M. Canis, C. Darcha, J.-L. Pouly, and G. Mage
HOXA-10 expression in the mid-secretory endometrium of infertile patients with either endometriosis, uterine fibromas or unexplained infertility
Hum. Reprod., December 1, 2009; 24(12): 3180 - 3187.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
L. A. Schieve, O. Devine, C. A. Boyle, J. R. Petrini, and L. Warner
Estimation of the Contribution of Non-Assisted Reproductive Technology Ovulation Stimulation Fertility Treatments to US Singleton and Multiple Births
Am. J. Epidemiol., December 1, 2009; 170(11): 1396 - 1407.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
M.M.E. van Rumste, I.M. Custers, F. van der Veen, M. van Wely, J.L.H. Evers, and B.W.J. Mol
The influence of the number of follicles on pregnancy rates in intrauterine insemination with ovarian stimulation: a meta-analysis
Hum. Reprod. Update, November 1, 2008; 14(6): 563 - 570.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
I. M. Custers, P. Steures, P. Hompes, P. Flierman, Y. van Kasteren, P. A. van Dop, F. van der Veen, and B. W.J. Mol
Intrauterine insemination: how many cycles should we perform?
Hum. Reprod., April 1, 2008; 23(4): 885 - 888.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. Dankert, J.A.M. Kremer, B.J. Cohlen, C.J.C.M. Hamilton, P.C.M. Pasker-de Jong, H. Straatman, and P.A. van Dop
A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility
Hum. Reprod., March 1, 2007; 22(3): 792 - 797.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Allegra, A. Marino, F. Coffaro, P. Scaglione, F. Sammartano, G. Rizza, and A. Volpes
GnRH antagonist-induced inhibition of the premature LH surge increases pregnancy rates in IUI-stimulated cycles. A prospective randomized trial
Hum. Reprod., January 1, 2007; 22(1): 101 - 108.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M.M.E. van Rumste, J.E. den Hartog, J.C.M. Dumoulin, J.L.H. Evers, and J.A. Land
Is controlled ovarian stimulation in intrauterine insemination an acceptable therapy in couples with unexplained non-conception in the perspective of multiple pregnancies?
Hum. Reprod., March 1, 2006; 21(3): 701 - 704.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S.J. Tanahatoe, C.B. Lambalk, and P.G.A. Hompes
The role of laparoscopy in intrauterine insemination: a prospective randomized reallocation study
Hum. Reprod., November 1, 2005; 20(11): 3225 - 3230.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A.J. Goverde, C.B. Lambalk, J. McDonnell, R. Schats, R. Homburg, and J.P.W. Vermeiden
Further considerations on natural or mild hyperstimulation cycles for intrauterine insemination treatment: effects on pregnancy and multiple pregnancy rates
Hum. Reprod., November 1, 2005; 20(11): 3141 - 3146.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J.R. Richmond, N. Deshpande, H. Lyall, R.W.S. Yates, and R. Fleming
Follicular diameters in conception cycles with and without multiple pregnancy after stimulated ovulation induction
Hum. Reprod., March 1, 2005; 20(3): 756 - 760.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J.L. Gomez-Palomares, B. Julia, B. Acevedo-Martin, M. Martinez-Burgos, E.R. Hernandez, and E. Ricciarelli
Timing ovulation for intrauterine insemination with a GnRH antagonist
Hum. Reprod., February 1, 2005; 20(2): 368 - 372.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
M. F. M. Mitwally and R. F. Casper
Aromatase Inhibition Reduces the Dose of Gonadotropin Required for Controlled Ovarian Hyperstimulation
Reproductive Sciences, September 1, 2004; 11(6): 406 - 415.
[Abstract] [PDF]


Home page
BMJHome page
R. Hart
Unexplained infertility, endometriosis, and fibroids
BMJ, September 27, 2003; 327(7417): 721 - 724.
[Full Text] [PDF]


Home page
Hum ReprodHome page
G. Makkar, E. H. Y. Ng, W. S. B. Yeung, and P. C. Ho
The significance of the ionophore-challenged acrosome reaction in the prediction of successful outcome of controlled ovarian stimulation and intrauterine insemination
Hum. Reprod., March 1, 2003; 18(3): 534 - 539.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
I. Ferrara, R. Balet, and J.G. Grudzinskas
Intrauterine insemination with frozen donor sperm. Pregnancy outcome in relation to age and ovarian stimulation regime
Hum. Reprod., September 1, 2002; 17(9): 2320 - 2324.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. Miskry and M. Chapman
The use of intrauterine insemination in Australia and New Zealand
Hum. Reprod., April 1, 2002; 17(4): 956 - 959.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P.S. Bhal, N.D. Pugh, L. Gregory, S. O'Brien, and R.W. Shaw
Perifollicular vascularity as a potential variable affecting outcome in stimulated intrauterine insemination treatment cycles: a study using transvaginal power Doppler
Hum. Reprod., August 1, 2001; 16(8): 1682 - 1689.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.